Par Pharmaceutical to Settle Off-Label Charges

Administrator 0 The Wall Street Journal - Health
Print Email

Par Pharmaceutical agreed to pay $45 million to settle allegations it improperly labeled and marketed its prescription drug Megace ES to elderly patients.
Read Full Article


x

You can contact us at:
info@realtruthtalks.com